Mass and generalized Thiele equation of the magnetic skyrmion

An analytical expression is obtained to the mass of an isolated magnetic skyrmion and its linearized equation of motion. The magnetic skyrmion is viewed as a topologically protected spin-wave soliton in the magnetic ultrathin films stabilized by the interfacial-Dzyaloshinskii-Moriya interaction. The equations of motion are derived from the Landau-Lifshitz-Gilbert equation for both the skyrmion charge and magnetization centers. They are generalized Thiele equations, including gyro-term, dissipation term, external force, an acceleration term with the tensorial mass, and time derivatives of the external forces. The equation of motion of the center of the skyrmion charge essentially shows the massless nature of the skyrmion. In contrast, the equation of motion for the magnetization center results in a finite mass that is in the same order as the Doring mass density for the linear domain wall. Furthermore, the time derivative of the external force predominantly contributes to the immediate response of the skyrmion motion, i.e., the mass-less property remains even after the skyrmion acquires its kinetic mass. A micromagnetic simulation based on the LLG equation was performed for various magnetic parameters. Obtained trajectories at 0 K are compared with the theoretical predictions.Comment: 28 pages, 3 figure

Manipulating 1-dimensinal skyrmion motion by external magnetic field gradient

We have investigated an analytic formula of the 1-dimensional magnetic skyrmion dynamics under external magnetic field gradient. We find excellent agreement between the analytical model and micromagnetic simulation results for various magnetic parameters such as the magnetic field gradient, Gilbert damping constant. We also observe much faster velocity of the chiral domain wall (DW) motion. The chiral DW is exist with smaller interfacial Dzyaloshinskii-Moriya interaction energy density cases. These results provide to develop efficient control of skyrmion for spintronic devices.Comment: 15 pages, 5 figures, 1 tabl

Improvement of the SOD activity of the Cu2+ complexes by hybridization with lysozyme and its hydrogen bond effect on the activity enhancement

We prepared L-amino acids (L-valine and L-serine, respectively) based on the Schiff base Cu2+ complexes CuSV and CuSS in the absence/presence of hydroxyl groups and their imidazole-bound compounds CuSV-Imi and CuSS-Imi to reveal the effects of hydroxyl groups on SOD activity. The structural and spectroscopic features of the Cu2+ complexes were evaluated using X-ray crystallography, UV-vis spectroscopy, and EPR spectroscopy. The spectroscopic behavior upon addition of lysozyme indicated that both CuSV and CuSS were coordinated by the imidazole group of His15 in lysozyme at their equatorial position, leading to the formation of hybrid proteins with lysozyme. CuSS-Imi showed a higher SOD activity than CuSV-Imi, indicating that the hydroxyl group of CuSS-Imi played an important role in the disproportionation of O2− ion. Hybridization of the Cu2+ complexes CuSV and CuSS with lysozyme resulted in higher SOD activity than that of CuSV-Imi and CuSS-Imi. The improvements in SOD activity suggest that there are cooperative effects between Cu2+ complexes and lysozyme

Metastases of soft tissue sarcoma to the liver: A Historical Cohort Study from a Hospital-based Cancer Registry

Background: Hepatic metastasis of soft tissue sarcoma is rare compared to lung metastasis, and the literature is scarce. We examined the risk of hepatic metastasis according to the site of occurrence and histological type. Methods: From a Hospital-based Cancer Registry, 658 patients registered between 2007 and 2017 with soft tissue sarcomas were evaluated. The exclusion criteria were gastrointestinal stromal tumors, tumors of unknown origin, and follow-up periods of less than 1 month. SPSS 25 was used for statistical analysis. Results: The risk of hepatic metastasis was significantly higher in the retroperitoneum (HR, 5.981; 95% CI, 2.793-12.808) and leiomyosarcoma (HR, 4.303; 95% CI, 1.782-10.390). Multivariate analysis showed that the risk of hepatic metastasis as first distant metastasis was high in leiomyosarcoma (HR, 4.546; 95% CI, 2.275-9.086) and retroperitoneal onset (HR, 4.588; 95% CI, 2.280-9.231). The 2-year survival rate after hepatic metastasis was 21.7%. Conclusions: The onset of hepatic metastasis indicates a poor prognosis. However, hepatic metastasis from retroperitoneal sarcoma and leiomyosarcoma may be the first distant metastasis in some cases. For retroperitoneal sarcoma and leiomyosarcoma, additional screening for hepatic metastasis such as contrast CT should be considered during staging and follow-up after treatment.ArticleCancer medicine 17(17) : 6159-6165(2020)journal articl